|
Group 1 (n = 17)
|
Group 2 (n = 13)
|
Group 3 (n = 30)
|
p-value
|
---|
Age (years)
|
67.9 ± 4.5
|
66.4 ± 6.9
|
72.1 ± 7.6
|
0.07
|
Sex (M/F)
|
7/10
|
3/10
|
12/18
|
0.52
|
Cause of revision
| | | |
0.6
|
PJI
|
14(82.4%)
|
9(69.2%)
|
24(80%)
|
Aseptic loosening
|
2(11.8%)
|
3(23.1%)
|
5(16.7%)
|
Instability
|
0
|
1(7.7%)
|
1(3.3%)
|
PE wear
|
1(5.9%)
|
0
|
0
|
Bone defect
|
Femur
|
I
|
0
|
2(15.4%)
|
1(3.3%)
|
0.14
|
IIA
|
2(11.8%)
|
1(7.7%)
|
0
|
IIB
|
15(88.2%)
|
9(69.2%)
|
25(83.3%)
|
III
|
0
|
1(7.7%)
|
4(13.3%)
|
Tibia
|
I
|
11(64.7%)
|
7(53.8%)
|
12(40%)
|
0.42
|
IIA
|
2(11.8%)
|
4(30.8%)
|
10(33.3%)
|
IIB
|
4(23.5%)
|
2(15.4%)
|
8(26.7%)
|
III
|
0
|
0
|
0
|
Knee scores
|
KSKS
|
46.5 ± 10.7
|
38.7 ± 8.6
|
43.2 ± 11.2
|
0.12
|
KSFS
|
39.4 ± 13.4
|
33.8 ± 10.8
|
41.7 ± 13.9
|
0.21
|
WOMAC
|
84.4 ± 14.4
|
88.8 ± 7.0
|
87.8 ± 8.2
|
0.87
|
Range of motion(°)
|
104.7 ± 15.5
|
105 ± 28.9
|
95.3 ± 27.7
|
0.54
|
Weight (kg)
|
61.1 ± 12.6
|
59.5 ± 9.3
|
59.8 ± 13.7
|
0.79
|
Height(m)
|
1.55 ± 0.09
|
1.52 ± 0.05
|
1.54 ± 0.12
|
0.6
|
BMI (kg/m2)
|
25.3 ± 4.6
|
25.8 ± 3.0
|
25.2 ± 4.5
|
0.85
|
Follow up period (months)
|
66.1 ± 9.7
|
63.3 ± 10.3
|
60.7 ± 8.1
|
0.03
|
- Data are presented as mean ± standard deviation or number (percentage), unless otherwise stated